About the Authors

Ivone Jimenez-Toro

Roles Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

Affiliations GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia, Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia

Carlos A. Rodriguez

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – review & editing

andres.rodriguez@udea.edu.co

Affiliations GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia, Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia

Andres F. Zuluaga

Roles Conceptualization, Funding acquisition, Project administration, Resources, Writing – review & editing

Affiliations GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia, Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia

Julian D. Otalvaro

Roles Formal analysis, Software, Writing – review & editing

Affiliation Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia

Omar Vesga

Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

Affiliations GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia, Infectious Diseases Unit, Hospital Universitario San Vicente Fundación, Medellín, Colombia

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: CAR has received honoraria for lectures on the therapeutic equivalence of generics and biosimilars from Allergan, Biosidus, Novartis and Pfizer, unrelated to this research project. AFZ has received honoraria for advisory boards and lectures on generics and biomilars therapeutic equivalence not related to the content of this paper from Allergan, Amgen, Janssen, Lilly, Merck, Novartis, Novo Nordisk, Pfizer, Roche and Sanofi. None of these companies or any other were involved in the design, execution, or publication of this study. IJT, JDO and OV have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.